Last reviewed · How we verify

NCT04249011

WatchPAT Compared to PSG at 8500'

Completed Last updated 30 January 2020
What this trial tests

trial in Sleep Disorder; Breathing-Related in 22 participants. Completed in 10 December 2019.

Timeline
2 May 2018
Primary endpoint
14 August 2018
10 December 2019

Quick facts

Lead sponsorItamar-Medical, Israel
StatusCompleted
Study typeOBSERVATIONAL
Enrollment22
Start date2 May 2018
Primary completion14 August 2018
Estimated completion10 December 2019
Sites1 location across United States

Conditions studied

Sponsor

Itamar-Medical, Israel — full company profile →

Who can join

17 and older, any sex, with Sleep Disorder; Breathing-Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Subjects who consent to participate in the research will undergo a simultaneous recording of inlab PSG and WatchPAT200 for comparing the WatchPAT data to PSG at an altitude of 8500'.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep Disorder; Breathing-Related

Currently open trials in the same condition.

Other Itamar-Medical, Israel trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04249011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing